Lung adenocarcinoma patient progression with gastrointestinal metastasis response to subsequent tyrosine kinase inhibitors (TKIs) from re-biopsy of new occurring driver gene mutation

Gene Mutation ◽

Kinase Inhibitors ◽

Driver Gene ◽

Gastrointestinal Metastasis ◽

Lung Adenocarcinoma Patient

A framework for risk stratification in EGFR+ lung adenocarcinoma treated with tyrosine kinase inhibitors

10.1055/s-0039-1678022 ◽

2019 ◽

Author(s):

P Christopoulos ◽

M Kirchner ◽

F Bozorgmehr ◽

N Magios ◽

AL Volckmar ◽

...

Keyword(s):

Risk Stratification ◽

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Kinase Inhibitors

A bicenter study on adjuvant surgery following treatment with tyrosine kinase inhibitors in patients with advanced lung adenocarcinoma

Interactive Cardiovascular and Thoracic Surgery ◽

10.1093/icvts/ivy120 ◽

2018 ◽

Vol 27 (4) ◽

pp. 598-601 ◽

Cited By ~ 1

Author(s):

Ludovic Fournel ◽

Pierre-Emmanuel Falcoz ◽

Audrey Mansuet-Lupo ◽

Elena Garelli ◽

Filippo Lococo ◽

...

Keyword(s):

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Kinase Inhibitors ◽

Adjuvant Surgery

Efficacy of pemetrexed and carboplatin with or without bevacizumab in lung adenocarcinoma patients with EGFR non-T790M mutations after progression on first-line EGFR-tyrosine kinase inhibitors

Thoracic Cancer ◽

10.1111/1759-7714.12814 ◽

2018 ◽

Vol 9 (9) ◽

pp. 1151-1155 ◽

Cited By ~ 3

Author(s):

Zhansheng Jiang ◽

Yu Zhang ◽

Yinli Yang ◽

Zhensong Yue ◽

Zhanyu Pan

Keyword(s):

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Kinase Inhibitors ◽

First Line ◽

Egfr Tyrosine Kinase ◽

Abstract 742: Effect of Hsp90 inhibitor NVP-AUY922 with radiation on lung adenocarcinoma cell lines with acquired resistance to EGFR-tyrosine kinase inhibitors

10.1158/1538-7445.am2015-742 ◽

2015 ◽

Author(s):

Yuho Maki ◽

Shinsuke Hashida ◽

Hiromasa Yamamoto ◽

Kazuhiko Shien ◽

Tomoaki Ohtsuka ◽

...

Keyword(s):

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Cell Lines ◽

Kinase Inhibitors ◽

Acquired Resistance ◽

Hsp90 Inhibitor ◽

Adenocarcinoma Cell ◽

Egfr Tyrosine Kinase ◽

Outcome of patients with lung adenocarcinoma with transformation to small-cell lung cancer following tyrosine kinase inhibitors treatment: A systematic review and pooled analysis

Cancer Treatment Reviews ◽

10.1016/j.ctrv.2017.07.007 ◽

2017 ◽

Vol 59 ◽

pp. 117-122 ◽

Cited By ~ 15

Author(s):

Elisa Roca ◽

Cristina Gurizzan ◽

Vito Amoroso ◽

William Vermi ◽

Vittorio Ferrari ◽

...

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Small Cell Lung Cancer ◽

Kinase Inhibitors ◽

Pooled Analysis ◽

Small Cell ◽

Small Cell Lung

A Young Adult Case of Poorly Differentiated Lung Adenocarcinoma Showing the Resistance Mutation T790M of EGFR before Treatment with Tyrosine Kinase Inhibitors.

Nihon Naika Gakkai Zasshi ◽

10.2169/naika.100.1959 ◽

2011 ◽

Vol 100 (7) ◽

pp. 1959-1962

Author(s):

Takashi Okamura ◽

Nobuyuki Shibusawa ◽

Yasuhiko Koga ◽

Norio Horiguchi ◽

Tuyoshi Ogashiwa ◽

...

Keyword(s):

Young Adult ◽

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Kinase Inhibitors ◽

Resistance Mutation ◽

Adult Case ◽

Poorly Differentiated

Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma

Current Drug Discovery Technologies ◽

10.2174/1570163813666160524142846 ◽

2016 ◽

Vol 13 (2) ◽

pp. 68-76 ◽

Cited By ~ 6

Author(s):

Akash Verma ◽

Akhil Chopra ◽

Yeo W. Lee ◽

Lavina D. Bharwani ◽

Atasha B. Asmat ◽

...

Keyword(s):

Pleural Effusion ◽

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Malignant Pleural Effusion ◽

Kinase Inhibitors ◽

Talc Pleurodesis ◽

Egfr Tyrosine Kinase ◽

An activation of LC3A-mediated autophagy contributes tode novoand acquired resistance to EGFR tyrosine kinase inhibitors in lung adenocarcinoma

The Journal of Pathology ◽

10.1002/path.4354 ◽

2014 ◽

pp. n/a-n/a ◽

Cited By ~ 9

Author(s):

Kaito Nihira ◽

Yasuhiro Miki ◽

Shinya Iida ◽

Sodai Narumi ◽

Katsuhiko Ono ◽

...

Keyword(s):

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Kinase Inhibitors ◽

Acquired Resistance ◽

Egfr Tyrosine Kinase ◽

Acquired Resistance to EGFR Tyrosine Kinase Inhibitors is Associated With Low Efficacy of Radiation Therapy for Brain Metastases From EGFR-mutant Lung Adenocarcinoma

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2012.07.166 ◽

2012 ◽

Vol 84 (3) ◽

pp. S102

Author(s):

H. Hirata ◽

K. Nakamura ◽

N. Kunitake ◽

Y. Shioyama ◽

T. Sasaki ◽

...

Keyword(s):

Radiation Therapy ◽

Brain Metastases ◽

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Kinase Inhibitors ◽

Acquired Resistance ◽

Egfr Tyrosine Kinase ◽

Egfr Tyrosine Kinase Inhibitors ◽

Egfr Mutant

Unusual Presentation of Lung Adenocarcinoma With Paraneoplastic Stiff Person Syndrome: Role of EGFR Tyrosine Kinase Inhibitors

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2019.03.025 ◽

2019 ◽

Vol 14 (8) ◽

pp. e179-e180

Author(s):

Nawid Sarwari ◽

Yehuda Galili ◽

Ariel Perez ◽

Nicholas Avgeropoulos ◽

Jennifer Tseng

Keyword(s):

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Kinase Inhibitors ◽

Unusual Presentation ◽

Stiff Person Syndrome ◽

Egfr Tyrosine Kinase ◽